CJPR

Previous Articles     Next Articles

  

  • Online:2021-08-01 Published:2021-08-10

分化型甲状腺癌术后颈淋巴结持续或复发治疗进展

曲    幽,张    浩   

  1. 中国医科大学附属第一医院甲状腺外科,辽宁沈阳110001

Abstract: Progress in the treatment of persistent or recurrent cervical lymph nodes of postoperative differentiated thyroid carcinoma        QU You, ZHANG Hao. Department of Thyroid Surgery,the First Hospital of China Medical University,Shenyang 110001,China
Corresponding author:ZHANG Hao,E-mail:haozhang@cmu.edu.cn
Abstract    Cervical lymph node recurrence is the most important part of the recurrence of differentiated thyroid cancer, and the main treatment is reoperation. In recent years, some alternative treatments such as active monitoring, radiofrequency ablation and radioiodine therapy have gradually been proposed. The effects and complications of these treatment methods are still controversial. Reoperation is still the preferred treatment. Radioiodine therapy after reoperation may not improve the prognosis of patients. Radiofrequency ablation should only be applied to patients who are not suitable for reoperation.

Key words: thyroid cancer, recurrence, persistent, reoperation, radioiodine therapy, radiofrequency ablation

摘要: 颈淋巴结复发是分化型甲状腺癌复发中最主要的一部分,其治疗的主要方案为再手术治疗。近年来一些如主动监测、射频消融、放射性碘治疗等代替手术治疗的方案逐渐被提出。部分治疗手段的效果及并发症仍有争议,再手术仍是首选的治疗方式,再术后的放射性碘治疗可能不会改善病人的预后,射频消融应仅限应用于不适合再次手术治疗的病人。

关键词: 甲状腺癌, 复发, 持续, 再手术, 放射性碘治疗, 射频消融